Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.

N Engl J Med. 2020 Jan 02;382(1):92

Authors: Biemans VBC, Hoentjen F, Pierik MJ

PMID: 31875506 [PubMed – in process]